Swedish Orphan Biovitrum AB (publ) provided earnings guidance for the year 2022. For the year, the company expects revenue to grow by a mid to high single-digit percentage at CER (unchanged).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
282.2 SEK | +5.93% | +9.95% | +6.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.82% | 8.31B | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.28% | 29.36B | |
+57.29% | 24.49B | |
-12.21% | 17.31B | |
-17.65% | 11.62B | |
-13.96% | 11.31B | |
-44.23% | 11.26B | |
-9.82% | 7.9B |
- Stock Market
- Equities
- SOBI Stock
- News Swedish Orphan Biovitrum AB
- Swedish Orphan Biovitrum AB Provides Earnings Guidance for the Year 2022